Day: February 25, 2021

US Ecology Announces Fourth Quarter and Full Year 2020 Results; Initiates 2021 Business Outlook

FOURTH QUARTER HIGHLIGHTS COMPARED TO PRIOR YEAR:Revenue of $241.1 million, up 4% including NRCBase Business revenue declined 8%; Event Business revenue declined 3%Field Services revenue grew 16%, excluding NRCGoodwill and intangible asset impairment charges of $104.6 millionNet loss of $92.4 million, or $2.97 per diluted shareAdjusted earnings per diluted share of $0.19Adjusted EBITDA of $42.8 millionStrong quarterly adjusted free cash flow generation, up 31% to $17.3 millionNet debt of $712.0 million, down from $727.9 million at December 31, 20192021 BUSINESS OUTLOOK:Revenue expected to range from $940 million to $990 millionAdjusted earnings per diluted share expected to range from $0.65 to $0.88Adjusted EBITDA expected to range from $175 million to $185 millionAdjusted free cash flow expected to range from $60 million to $77 millionCapital...

Continue reading

Borqs Technologies Completes $20 Million Private Placement to Support Growth

SANTA CLARA, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) — Borqs Technologies, Inc. (Nasdaq: BRQS, the “Company”), a global provider of embedded software and products for the Internet of Things (IoT), reported today that the Company has signed agreements with institutional and individual investors on February 25, 2021 for sale of $20 million in convertible notes. The notes are due in two years, have an annual interest rate of 8%,    convertible into ordinary shares of Borqs at 10% discount from the market price and has 90% warrant coverage with the warrants exercisable at 110% of the conversion price. One-third of the notes are sold at the execution of definitive agreements and two-thirds of the notes will be sold upon the satisfaction of certain conditions, including effectiveness of a registration statement to be filed by the Company...

Continue reading

Profound Medical to Participate in March Virtual Investor Conferences

TORONTO, Feb. 25, 2021 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, announced today that management will participate in two investor conferences in March.Raymond James 42nd Annual Institutional Investors Conference: Profound is scheduled to participate in a fireside chat on Wednesday, March 3, 2021 at 7:30 a.m. ET.Cowen 41st Annual Health Care Conference: Profound is scheduled to participate in a fireside chat on Thursday, March 4, 2021 at 9:10 a.m. ET.The fireside chats will be broadcast live and archived on the Company’s website at www.profoundmedical.com under “Webcasts” in the Investors section.About Profound Medical Corp.Profound is...

Continue reading

NexGen Announces C$150 Million Bought Deal Financing

VANCOUVER, British Columbia, Feb. 25, 2021 (GLOBE NEWSWIRE) — NexGen Energy Ltd. (“NexGen” or the “Company“) (TSX:NXE, NYSE:NXE) is pleased to announce that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets and Canaccord Genuity Corp. and under which the underwriters have agreed to buy on a bought deal basis 33,400,000 common shares of the Company (the “Common Shares”) at a price of C$4.50 per Common Share (the “Offering Price”) for gross proceeds of approximately C$150 million (the “Offering”). The Company has granted the Underwriters an option, exercisable at the Offering Price for a period of 30 days following the closing of the Offering, to purchase up to an additional 5,010,000 Common Shares to cover over-allotments, if any. The Offering is expected to close...

Continue reading

Urbanimmersive Signs Letter of Intent with MLS Market Leading Mobile App, Prospects.com

SAINT-HUBERT, Quebec, Feb. 25, 2021 (GLOBE NEWSWIRE) — Urbanimmersive Inc. (“Urbanimmersive”, the “Company” or “UI”) (TSX VENTURE: UI) (OTCQB: UBMRF) is pleased to announce today that the Company has signed a letter of intent (“LOI”) with Prospect Software Inc. (“Prospects” or “Prospects Software”), a leading real estate software solution including Prospects CRM, Prospects Mobile in Canada and MLS-Touch in the United States (Prospects.com) and offered to nearly 400,000 real estate agents in North America.Under this LOI, both parties engage to partner in sharing resources, knowhow and technologies to establish a seamless integration of Urbanimmersive’s 3D tours technology within the Prospects app and software. The integration will allow Prospects’ users to easily capture 360 images, produce 3D tours and book 3D...

Continue reading

Urbanimmersive signe une lettre d’intention avec le leader du marché des applications mobiles pour MLS®, Prospects.com

SAINT-HUBERT, Québec, 25 févr. 2021 (GLOBE NEWSWIRE) — Urbanimmersive Inc. (« Urbanimmersive », la « Société » ou « UI ») (TSX CROISSANCE : UI) (OTCQB : UBMRF) est fière d’annoncer aujourd’hui que la Société a signé une lettre d’intention (« LOI ») avec Prospect Software Inc. (« Prospects » ou « Prospects Software »), une solution logicielle immobilière de premier plan qui inclut Prospects CRM, Prospects Mobile au Canada et MLS-Touch aux États-Unis (Prospects.com) et est offerte à près de 400 000 agents immobiliers en Amérique du Nord.Dans le cadre de cette lettre d’intention, les deux parties s’engagent à s’associer pour le partage de ressources, de savoir-faire et de technologies afin d’établir une intégration sans faille de la technologie de visites immersives 3D d’Urbanimmersive dans l’application mobile...

Continue reading

Extended Stay America Announces Fourth Quarter and Full Year 2020 Results

–  Net income of $65.7 million in the Fourth Quarter, $96.3 million for the Full Year 2020–  Adjusted EBITDA1of $89.3 million in the Fourth Quarter, $374.1 million for the Full Year 2020–  Comparable system-wide RevPAR decrease of 9.4% in the Fourth Quarter, -15.0% for the Full Year 2020–  Announces quarterly distribution of $0.09 per Paired Share–  RevPAR Index increased 40% to 140 in the Fourth Quarter, +31.6% to 127 for the Full Year 20202CHARLOTTE, N.C., Feb. 25, 2021 (GLOBE NEWSWIRE) — Extended Stay America, Inc. (“ESA”) and ESH Hospitality, Inc. (NASDAQ:STAY) (together, the “Company”) today announced consolidated results for the three months and full year ended December 31, 2020.  Fourth Quarter 2020 HighlightsNet income of $65.7 millionTotal revenues of $259.3 millionComparable system-wide Revenue...

Continue reading

FTAI Reports Fourth Quarter and Full Year 2020 Results, Dividend of $0.33 per Common Share

NEW YORK, Feb. 25, 2021 (GLOBE NEWSWIRE) — Fortress Transportation and Infrastructure Investors LLC (NYSE:FTAI) (the “Company” or “FTAI”) today reported financial results for the quarter and full year ended December 31, 2020. The Company’s consolidated comparative financial statements and key performance measures are attached as an exhibit to this press release.Financial Overview________________________________(1) For definitions and reconciliations of non-GAAP measures, please refer to the exhibit to this press release.For the fourth quarter of 2020, total FAD was $54.2 million. This amount includes $89.9 million from our aviation leasing portfolio, offset by $(1.8) million from our infrastructure business and $(33.9) million from corporate and other.Fourth Quarter 2020 DividendsOn February 25, 2021, the Company’s Board of Directors...

Continue reading

SCYNEXIS to Participate in Maxim Group’s Late Stage Innovations in Women’s Health Virtual Event

JERSEY CITY, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that Marco Taglietti, President and Chief Executive Officer, will participate in a panel discussion during Maxim Group LLC’s Late Stage Innovations in Women’s Health event, which is part of the M-Vest Virtual Conference series. The virtual event will take place at 11:00 am Eastern Time on March 4, 2021.The panel will be moderated by Jason McCarthy, PhD, Senior Managing Director and Head of Biotechnology Research – Equity Research at Maxim Group.During the panel discussion, Dr. Taglietti will share insight on Brexafemme, an oral antifungal product candidate under review by the U.S. Food and Drug Administration...

Continue reading

Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results

SAN FRANCISCO, Feb. 25, 2021 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2020.“Vir closed 2020 delivering strong progress across our entire development pipeline with six distinct molecules addressing four serious infectious diseases. Our momentum continues in 2021 with the signing of new collaborations designed to help speed the development of multiple promising candidates, as well as pending data from two Phase 3 studies evaluating our novel monoclonal antibody, VIR-7831, against COVID-19,” said George Scangos, Ph.D., chief executive officer of Vir Biotechnology. “Additionally, we are now evaluating an intramuscular formulation of VIR-7831, and expect the first trial evaluating VIR-7832, our second...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.